about
Contribution of efflux to the emergence of isoniazid and multidrug resistance in Mycobacterium tuberculosisDirect Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West AfricaIon Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosisRelatedness of Mycobacterium avium subspecies hominissuis clinical isolates of human and porcine origins assessed by MLVA.Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosisExploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureusThe variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugs.Assessment of the BD MGIT TBc identification test for the detection of Mycobacterium tuberculosis complex in a network of mycobacteriology laboratories.Molecular tools for rapid identification and novel effective therapy against MDRTB/XDRTB infections.Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli.Genetic diversity, transmission dynamics, and drug resistance of Mycobacterium tuberculosis in Luanda, Angola.Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery.Revisiting susceptibility testing in MDR-TB by a standardized quantitative phenotypic assessment in a European multicentre study.Genetic diversity, transmission dynamics and drug resistance of Mycobacterium tuberculosis in AngolaEnhancement of antibiotic activity by efflux inhibitors against multidrug resistant Mycobacterium tuberculosis clinical isolates from BrazilRapid identification of veterinary-relevant Mycobacterium tuberculosis complex species using 16S rDNA, IS6110 and Regions of Difference-targeted dual-labelled hydrolysis probes.An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria.Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium.High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.Gold nanoprobes for multi loci assessment of multi-drug resistant tuberculosis.Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy.Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex.The role of efflux pumps in macrolide resistance in Mycobacterium avium complex.HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality.Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance.GidB mutation as a phylogenetic marker for Q1 cluster Mycobacterium tuberculosis isolates and intermediate-level streptomycin resistance determinant in Lisbon, Portugal.Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.Correction: Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Staphylococcus aureus.Insights on the Mechanism of Action of INH-C10 as an Antitubercular Prodrug.Methylation in Mycobacterium tuberculosis is lineage specific with associated mutations present globally.Beyond extensively drug-resistant tuberculosis in Lisbon, Portugal: a case of linezolid resistance acquisition presenting as an iliopsoas abscess.From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition.Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains.Clonal expansion across the seas as seen through CPLP-TB database: A joint effort in cataloguing Mycobacterium tuberculosis genetic diversity in Portuguese-speaking countriesGenomic diversity of drug-resistant Mycobacterium tuberculosis isolates in Lisbon Portugal: Towards tuberculosis genomic epidemiologyAdjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energeticsContribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolateEmergence of High-Level Colistin Resistance in an Acinetobacter baumannii Clinical Isolate Mediated by Inactivation of the Global Regulator H-NSChallenging the Drug-Likeness Dogma for New Drug Discovery in Tuberculosis
P50
Q28482174-8A17AA0C-C279-420B-BAC3-0F65F5BAFCB2Q28547525-263C631A-582A-450A-AC09-696ACBFE5770Q28550401-E913E594-CC79-4215-BBF1-A2DC2BAAE48CQ30487186-006F86AD-659F-4593-91FC-8794A09F9042Q33607162-B38F50A6-F7F0-459A-B650-B210B900A05BQ34059927-FA973520-F3E6-4E0A-84A9-6975FFB478B0Q36230709-A5369716-DB20-4CD4-A04E-A95163F9669DQ37577491-2F11A054-A70C-43B9-968E-C668B6AD13BBQ37727181-BD4483D9-422C-41C6-A457-B1A34F38DD2EQ38056146-EAA19349-C80B-4965-A98C-F51F2D9ADFE4Q38682599-D46ECC2F-E47C-4225-9F17-FAFCC226834CQ38775511-CA6D1477-5CCC-4C51-ABA7-536D81E5B21EQ38886183-8570873D-D7D5-4D39-B5E8-6378884397E0Q38929849-4B3C4407-3C76-4056-90F6-1EC28D9CBB9CQ38946645-8A78239D-D154-4235-B1CF-1E573181D4CBQ38949658-AFC372E5-7CD1-48F5-87F1-88EC787EC834Q38954218-FE11D88A-195F-49C4-A6C1-72F7BF2A13C6Q38954266-084188AA-4A51-4D73-B052-1E917DDD0085Q39200033-21310EDD-9D14-4972-8F18-61008A46224CQ39200043-FA4EE660-0E88-4A72-A9EE-1E38BFF823F9Q39346142-FDAFB3A0-7E0F-4D2B-B61B-8EAB29CC7B0BQ39355775-70DA5EA6-4E20-4AC0-A04B-03C029FE462AQ39403996-ADFBE948-3F01-4CE0-ADFB-546F09A22940Q39404012-E5C832C4-AA54-4CF6-93CA-E3A302C6F572Q41928670-40E0D92B-4BCF-4130-A1F7-68F8AA4B78DDQ41991754-DFB3C9DC-C583-47F7-B03B-4C9F64E01A71Q44301461-B7620ABD-701E-4CE5-ADC6-ED3F1CE46CB5Q46297984-E4AD3A7D-CF3A-4DAC-8803-EF0E33E0A9DDQ46506425-FA155FA7-C0DC-48E5-B79E-2DF9240BA79DQ47817992-65B78CDC-7974-4438-908A-50F20D29006DQ48276217-20ED2F71-86B0-465A-A48D-0002BF4311D3Q52799726-7FA16E20-57C1-4192-8F23-200C242E6267Q52802359-1E639B6B-08CF-4EB0-90DD-DB900B869350Q53704257-DF9B8FEC-8121-4E2D-8E38-8911A684A27AQ54261664-8DB73D45-D15D-498B-98F6-5CD5B301E77AQ54261843-B8DEC126-3236-4C15-84D8-99E4DB552109Q57656274-834F3FB4-8D97-4502-AC2C-4179B7A27924Q57656295-CA42C7E3-AE5F-4269-A646-4C151957173DQ57656298-F6A99484-4112-4A90-80E9-DB20BBEAFE0BQ57656314-61A86F08-55B3-4AB1-AFB8-C2E63E01D516
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Diana Machado
@ast
Diana Machado
@en
Diana Machado
@es
Diana Machado
@nl
Diana Machado
@sl
type
label
Diana Machado
@ast
Diana Machado
@en
Diana Machado
@es
Diana Machado
@nl
Diana Machado
@sl
prefLabel
Diana Machado
@ast
Diana Machado
@en
Diana Machado
@es
Diana Machado
@nl
Diana Machado
@sl
P1053
L-7027-2013
P106
P1153
57193559333
P21
P2798
P31
P3829
P496
0000-0003-2375-2726